Home > Financial Ratios > WANBURY

WANBURY
Core EBITDA Growth

    Back to All Ratios
WANBURY is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for WANBURY
Please provide your vote to see the results

WANBURY Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 9.34203.06-34.5980.29-16.93

What is the latest Core EBITDA Growth ratio of WANBURY ?

The latest Core EBITDA Growth ratio of WANBURY is 9.34 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar20259.34
Mar2024203.06
Mar2023-34.59
Mar202280.29
Mar2021-16.93

How is Core EBITDA Growth of WANBURY Trending?

Years Core EBITDA Growth % Change
Mar2025 9.34
-95.40
Mar2024 203.06
Positive
Mar2023 -34.59
Negative
Mar2022 80.29
Positive
Mar2021 -16.93 -

Other Financial Ratios of WANBURY


Compare Core EBITDA Growth ratio of peers of WANBURY

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WANBURY ₹830.1 Cr 4.9% 2% -16.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹412,494.0 Cr -0.5% -1.9% -3% Stock Analytics
DIVIS LABORATORIES ₹170,514.0 Cr 1.8% 1.3% 10.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹129,044.0 Cr 2% 2.4% 11.2% Stock Analytics
CIPLA ₹121,574.0 Cr -0.2% -0.7% 1.9% Stock Analytics
DR REDDYS LABORATORIES ₹105,919.0 Cr -1% 2.5% -4.4% Stock Analytics


WANBURY Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
WANBURY

4.9%

2%

-16.7%

SENSEX

1%

0.6%

7.8%


You may also like the below Video Courses